Vandroux David, Aujoulat Thomas, Gaüzère Bernard-Alex, Puech Bérénice, Guihard Bertrand, Martinet Olivier
Intensive Care Unit, Félix Guyon Hospital, University Teaching Hospital of La Réunion, 97400 Saint Denis, Reunion Island, France.
Cardiosurgical Intensive Care Unit, Dupuytren II Hospital, University Teaching Hospital of Limoges, 87042 Limoges, France.
World J Emerg Med. 2022;13(4):283-289. doi: 10.5847/wjem.j.1920-8642.2022.070.
Severe poisoning due to the overdosing of cardiac drugs can lead to cardiovascular failure. In order to decrease the mortality rate, the most severe patients should be transferred as quickly as possible to an extracorporeal membrane oxygenation (ECMO) center. However, the predictive factors showing the need for venous-arterial ECMO (VA-ECMO) had never been evaluated.
A retrospective, descriptive, and single-center cohort study. All consecutive patients admitted in the largest ICU of Reunion Island (Indian Ocean) between January 2013 and September 2018 for beta-blockers (BB), calcium channel blockers (CCB), renin-angiotensin-aldosterone system blockers, digoxin or anti-arrythmic intentional poisonings were included. ECMO implementation was the primary outcome.
A total of 49 consecutive admissions were included. Ten patients had ECMO, 39 patients did not have ECMO. Three patients in ECMO group died, while no patients in the conventional group died. The most relevant ECMO-associated factors were pulse pressure and heart rate at first medical contact and pulse pressure, heart rate, arterial lactate concentration, liver enzymes and left ventricular ejection fraction (LVEF) at ICU-admission. Only pulse pressure at first medical contact and LVEF were significant after logistic regression.
A transfer to an ECMO center should be considered for a pulse pressure < 35 mmHg at first medical contact or LVEF < 20% on admission to ICU.
心脏药物过量导致的严重中毒可引发心血管衰竭。为降低死亡率,病情最严重的患者应尽快转至体外膜肺氧合(ECMO)中心。然而,此前从未评估过表明需要静脉-动脉ECMO(VA-ECMO)的预测因素。
一项回顾性、描述性单中心队列研究。纳入2013年1月至2018年9月期间在留尼汪岛(印度洋)最大的重症监护病房(ICU)连续收治的所有因β受体阻滞剂(BB)、钙通道阻滞剂(CCB)、肾素-血管紧张素-醛固酮系统阻滞剂、地高辛或抗心律失常药物蓄意中毒的患者。实施ECMO是主要结局。
共纳入49例连续入院患者。10例患者接受了ECMO治疗,39例患者未接受ECMO治疗。ECMO组有3例患者死亡,而常规治疗组无患者死亡。与ECMO最相关的因素是首次医疗接触时的脉压和心率,以及入住ICU时的脉压、心率、动脉血乳酸浓度、肝酶和左心室射血分数(LVEF)。经逻辑回归分析后,仅首次医疗接触时的脉压和LVEF具有显著性。
首次医疗接触时脉压<35 mmHg或入住ICU时LVEF<20%的患者应考虑转至ECMO中心。